Tyra Biosciences Soars 10.71% on Insider Buying

Tyra Biosciences' stock surged by 10.71% in pre-market trading on June 9, 2025, driven by significant insider buying activity. The company's Chairman and CEO purchased 5,000 shares at $9.50 each, totaling $47,500. Additionally, RA Capital Management, L.P., a 10% owner, acquired 1,211,198 shares at $9.70 per share, amounting to $11,751,304. This substantial investment by key insiders has bolstered investor confidence, contributing to the stock's impressive pre-market performance.

Tyra Biosciences' recent insider buying activities have been a focal point for investors. The company's Chairman and CEO, along with RA Capital Management, L.P., have made significant purchases, indicating a strong belief in the company's future prospects. These transactions have likely influenced the stock's recent surge, as insider buying is often seen as a positive signal for a company's performance.